eMedicine Specialties > Emergency Medicine > Toxicology

Plant Poisoning, Castor Bean and Jequirity Bean

Author: William Gluckman, DO, MBA, FACEP, Assistant Professor, Department of Surgery, Section of Emergency Medicine, University of Medicine and Dentistry of New Jersey, University Hospital; Attending Emergency Physician, St Joseph's Regional Medical Center; President and CEO, FastER Urgent Care
Coauthor(s): Gregory S Sugalski, MD, Staff Physician, Department of Emergency Medicine, University of Medicine and Dentistry of New Jersey Hospital
Contributor Information and Disclosures

Updated: Nov 21, 2008

Introduction

Background

Although castor and jequirity beans are an uncommon cause of poisoning, they remain a concern because their toxins are among the most lethal naturally occurring toxins known today. The beans most commonly are used for ornamental purposes, such as prayer or rosary beads, or in musical shakers (maracas).

The castor bean plant (Ricinus communis) is found primarily in Asia and Africa, but the plant has taken root in all temperate and subtropical regions around the world.
 

Castor bush.

Castor bush.

Castor bush.

Castor bush.


In fact, the castor bean plant grows in the southwest United States mainly along streams and riverbeds. Castor beans are oblong and brown in color with speckled dark brown spot.

Castor beans.

Castor beans.

Castor beans.

Castor beans.


Jequirity bean plant (Abrus precatorius) is primarily found in southeast Asia, but has spread to subtropical regions.

Jequirity bush.

Jequirity bush.

Jequirity bush.

Jequirity bush.


{{mediacaption:1009270_3}}  

The jequirity bean has a shiny appearance and is mainly red in color with a black spot.

Jequirity beans.

Jequirity beans.

Jequirity beans.

Jequirity beans.


For centuries, ricin and abrin, the toxin contained in the seeds of the castor and jequirity beans, respectively, have been used for homicidal purposes. The ease of production of ricin makes it very attractive as an agent that could be used by a terrorist or other criminal. The Centers for Disease Control and Prevention (CDC) categorizes ricin as a category B agent because it is moderately easy to disseminate while causing moderate-to-high morbidity in humans.

During the 1980s, the Iraqi government made weapon-grade ricin, and it was tested on animals and in artillery shells. In 2003, ricin was found in US Senator Bill Frist's office, and, in January of that same year, Arabs connected to Al-Qaeda were arrested in a London apartment while trying to manufacture ricin.1 In February 2008, a man was poisoned in a hotel room in Las Vegas, Nevada. Because of the ongoing threat of weapons of mass destruction (WMD) in the United States, physicians must become familiar with the diagnosis and treatment of poisonings due to substances such as ricin.

Pathophysiology

These beans contain potent toxalbumins that inhibit protein synthesis and cause severe cytotoxic effects on multiple organ systems. Castor beans contain the toxalbumin ricin, and jequirity beans contain abrin. The toxins are present in all parts of the plant but are most concentrated in the beans or seeds. Symptoms include delayed gastroenteritis, which may be severe and hemorrhagic, followed by delirium, seizures, coma, and death. The beans are covered by a hard, relatively impervious outer shell that must be chewed or broken in some way in order for the toxalbumin to be released and, thus, present a toxic hazard. Castor beans are particularly antigenic and may cause severe cutaneous hypersensitivity and systemic reactions.

Frequency

United States

Jequirity and castor bean ingestions are extremely uncommon. The American Association of Poison Control Centers (AAPCC) recorded 168 cases of toxalbumin cases.2 Of those 156 were single exposures, 53 of which were treated in a health care facility. No deaths were reported and only one was considered to have a major adverse reaction.

Mortality/Morbidity

Fatalities have occasionally been reported following ingestion of chewed castor beans. Chewing and swallowing as little as 1 bean may produce death in a child; however, swallowing an intact bean without chewing is unlikely to cause serious sequelae. Jequirity bean mortality is 5% for ingestion, and death may occur as long as 14 days after poisoning.

Clinical

History

  • Assess the usual significant features that are associated with toxic environmental exposures. This includes the following:
    • Identification of substance
    • Time and duration of exposure
    • Symptoms
    • Treatment thus far
    • Associated injuries
    • Preexisting conditions
  • Identification
    • Ask the parents to bring in a sample of the bean, if it is possible. Having the exact bean greatly aids in the identification process.
    • Knowing that beans are often known by various names, both common and scientific, is important.
  • Time and duration of exposure: Determine whether the child chewed or swallowed any beans.
  • Symptomatology
    • Following ingestion of jequirity beans, a latent period of about 3 days occurs, and symptoms may persist more than 10 days later. Patient may present with nausea, vomiting, diarrhea, abdominal cramps, hematemesis, and melena. In some cases, acute renal failure and hepatotoxicity may occur.
    • Drowsiness and seizures have been reported after jequirity bean ingestion. If eye contact is made, the patient may report eye irritation and blindness. Skin contact may result in a rash.
    • Following ingestion of castor beans, the patient may become symptomatic from 8-24 hours after exposure. The clinical picture may appear very similar to jequirity bean ingestion, with GI symptoms that can progress to hypotension, liver and renal failure, and death.
    • Inhalation of castor bean toxin can cause illness within 8 hours. Symptoms include cough, dyspnea, arthralgias, fever, respiratory distress, and death. Injection of ricin causes symptoms within 6 hours, which may include weakness and myalgias with progression of the illness to fever, hypotension, multiorgan failure, and death.
  • Prior treatment: Determine if any treatment has been administered to the child prior to presentation.
  • Associated injuries: Inquire about any other potential exposures or injury.
  • Preexisting conditions: Inquire about past medical history, medications, and allergies.

Physical

  • Assess airway patency. It is extremely uncommon to have any oral or upper airway swelling of sufficient magnitude to cause airway compromise. Breathing usually is unaffected. Circulation may become affected as shock develops, secondary to severe gastroenteritis.
  • Patients may develop severe cutaneous hypersensitivity or systemic allergic reactions. An urticarial, immunoglobulin E–mediated allergic reaction may occur with the development of tongue or facial swelling, bronchospasm, and acute upper airway obstruction.

Causes

  • Both castor and jequirity beans are commonly encountered as ornamental beans or seeds.
  • Castor and jequirity beans are commonly used as prayer beads, bracelets, or necklaces.
  • Castor and jequirity beans are also used as the seeds that rattle in maracas.

More on Plant Poisoning, Castor Bean and Jequirity Bean

Overview: Plant Poisoning, Castor Bean and Jequirity Bean
Differential Diagnoses & Workup: Plant Poisoning, Castor Bean and Jequirity Bean
Treatment & Medication: Plant Poisoning, Castor Bean and Jequirity Bean
Follow-up: Plant Poisoning, Castor Bean and Jequirity Bean
Multimedia: Plant Poisoning, Castor Bean and Jequirity Bean
References

References

  1. Audi J, Belson M, Patel M, et al. Ricin poisoning: a comprehensive review. JAMA. 2005;Nov 9;294(18):2342-51. [Medline].

  2. Bronstein AC, Spyker DA, Cantilena LR Jr, Green J, Rumack BH, Heard SE. 2006 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS). Clin Toxicol (Phila). Dec 2007;45(8):815-917. [Medline].

  3. Doan LG. Ricin: mechanism of toxicity, clinical manifestations, and vaccine development. A review. J Toxicol Clin Toxicol. 2004;42(2):201-8. [Medline].

  4. Challoner KR, McCarron MM. Castor bean intoxication. Ann Emerg Med. Oct 1990;19(10):1177-83. [Medline].

  5. Fernando C. Poisoning due to Abrus precatorius (jequirity bean). Anaesthesia. Dec 2001;56(12):1178-80. [Medline].

  6. Ferraz AC, Angelucci ME, Da Costa ML, et al. Pharmacological evaluation of ricinine, a central nervous system stimulant isolated from Ricinus communis. Pharmacol Biochem Behav. Jul 1999;63(3):367-75. [Medline].

  7. Kinamore PA, Jaeger RW, de Castro FJ. Abrus and ricinus ingestion: management of three cases. Clin Toxicol. Oct 1980;17(3):401-5. [Medline].

  8. Krenzelok EP, Jacobsen TD. Plant exposures ... a national profile of the most common plant genera. Vet Hum Toxicol. Aug 1997;39(4):248-9. [Medline].

  9. Navarro-Rouimi R, Charpin D. Anaphylactic reaction to castor bean seeds. Allergy. Oct 1999;54(10):1117. [Medline].

  10. Olsnes S. The history of ricin, abrin and related toxins. Toxicon. 2004;Sep 15;44(4):361-70. [Medline].

  11. Palatnick W, Tenenbein M. Hepatotoxicity from castor bean ingestion in a child. J Toxicol Clin Toxicol. 2000;38(1):67-9. [Medline].

  12. Rauber A. Plantlore revisited. J Toxicol Clin Toxicol. 1999;37(4):521-4. [Medline].

  13. Schwenk M, Kluge S, Jaroni H. Toxicological aspects of preparedness and aftercare for chemical-incidents. Toxicology. 2005;214(3):232-48. [Medline].

  14. Spivak L, Hendrickson RG. Ricin. Crit Care Clin. 2005;Oct;21(4):815-24, viii. [Medline].

  15. Vitetta ES, Smallshaw JE, Coleman E, et al. A pilot clinical trial of a recombinant ricin vaccine in normal humans. Proc Natl Acad Sci USA. 2006;103(7):2268-73. [Medline].

Further Reading

Keywords

castor bean, caster bean plant, caster bean seeds, caster bean poison, jequirity bean,  terrorism, ricin, gastroenteritis

Contributor Information and Disclosures

Author

William Gluckman, DO, MBA, FACEP, Assistant Professor, Department of Surgery, Section of Emergency Medicine, University of Medicine and Dentistry of New Jersey, University Hospital; Attending Emergency Physician, St Joseph's Regional Medical Center; President and CEO, FastER Urgent Care
William Gluckman, DO, MBA, FACEP is a member of the following medical societies: American College of Emergency Physicians and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Coauthor(s)

Gregory S Sugalski, MD, Staff Physician, Department of Emergency Medicine, University of Medicine and Dentistry of New Jersey Hospital
Gregory S Sugalski, MD is a member of the following medical societies: American Medical Association and Emergency Medicine Residents Association
Disclosure: Nothing to disclose.

Medical Editor

Michael E Mullins, MD, Assistant Professor, Department of Emergency Medicine, Washington University School of Medicine
Michael E Mullins, MD is a member of the following medical societies: American Academy of Clinical Toxicology and American College of Emergency Physicians
Disclosure: Johnson & Johnson stock ownership None; Savient Pharmaceuticals stock ownership None

Pharmacy Editor

Mary L Windle, PharmD, Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy, Pharmacy Editor, eMedicine
Disclosure: Pfizer Inc Stock Investment from financial planner; Avanir Pharma Stock Investment from financial planner ; WebMD Salary and stock Employment and investment from financial planner

Managing Editor

Jeffrey R Tucker, MD, Assistant Professor, Department of Pediatrics, Division of Emergency Medicine, University of Connecticut and Connecticut Children's Medical Center
Jeffrey R Tucker, MD is a member of the following medical societies: American Academy of Clinical Toxicology, American Academy of Pediatrics, and Massachusetts Medical Society
Disclosure: Merck Salary Employment

CME Editor

Paul D Petry, DO, FACOP, FAAP, Consulting Staff, Freeman Pediatric Care, Freeman Health System
Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association
Disclosure: Nothing to disclose.

Chief Editor

Timothy E Corden, MD, Associate Professor of Pediatrics, Co-Director, Policy Core, Injury Research Center, Medical College of Wisconsin; Associate Director, PICU, Children's Hospital of Wisconsin
Timothy E Corden, MD is a member of the following medical societies: American Academy of Pediatrics, Phi Beta Kappa, Society of Critical Care Medicine, and Wisconsin Medical Society
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.